Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT)

Study Overview
=================
Brief Summary
-----------------
This is a non randomized, monocentric, descriptive, transversal and prospective study. The purpose of this study is to assess the compliance with patient expressed choice regarding subsequent care and death -if occured- site (at hospital or at home) after hospitalisation for terminally ill patients with an onco-hematologic solid tumor in palliative care and to identify reasons for potential non-compliance.

Detailed Description
-----------------
Patients will reply to two questionnaires, at inclusion and two months after inclusion. Primary care physician will also be contacted by phone to reply to two questionnaires, at inclusion and two months after inclusion.

Official Title
-----------------
Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site

Conditions
-----------------
Hematologic Malignancy, Tumor, Solid

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients must be ≥ 18 years old Patients with onco-hematologic solid tumor (locally advanced or metastatic) against which specific and systemic treatments are outdated or have been stopped (symptomatic palliation with radiotherapy is allowed) Patients admitted in full hospitalisation Patients able to speak, read and understand French Patients able to answer the phone Signed informed consent from the patient Patients must have a social security coverage Exclusion Criteria: Patients < 18 years old or incapable person ≥ 18 years old Patients admitted for any surgical intervention Patients unable to read French Patients whose physical or psychological condition do not allow them to answer orally or in writing Patients deprived of liberty Patients placed under judicial protection Women that are pregnant or breast-feeding

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with an onco-hematologic solid tumor in palliative care<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of patients for which their choice of care and death -if occured- site (at hospital or at home) is respected. | Patients will fill out a questionnaire at inclusion and 2 months after inclusion if they are still alive. Death site will be collected from primary care physician if patient died. The patient expressed choice regarding subsequent care and death site collected in the first questionnaire at inclusion will be compared to the situation at 2 months. | 2 months after inclusion | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of new hospitalisations occuring after inclusion, if any. |  | 2 months after inclusion | 
| Duration of new hospitalisations occuring after inclusion, if any. |  | 2 months after inclusion | 
| Reasons for new hospitalisations occuring after inclusion, if any. |  | 2 months after inclusion |